Cargando…
ERCC1 intron 1 was associated with breast cancer risk
INTRODUCTION: There are numerous studies addressing associations of polymorphisms in DNA repair genes and cancer risks because accurate and efficient DNA repair is crucial to genomic integrity and fidelity. ERCC1 is important in DNA nucleotide excision repair. MATERIAL AND METHODS: We genotyped cons...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460502/ https://www.ncbi.nlm.nih.gov/pubmed/23056077 http://dx.doi.org/10.5114/aoms.2012.30289 |
_version_ | 1782244946689916928 |
---|---|
author | Mojgan, Hosseini Massoud, Houshmand Ahmad, Ebrahimi |
author_facet | Mojgan, Hosseini Massoud, Houshmand Ahmad, Ebrahimi |
author_sort | Mojgan, Hosseini |
collection | PubMed |
description | INTRODUCTION: There are numerous studies addressing associations of polymorphisms in DNA repair genes and cancer risks because accurate and efficient DNA repair is crucial to genomic integrity and fidelity. ERCC1 is important in DNA nucleotide excision repair. MATERIAL AND METHODS: We genotyped constitutive variants of ERCC1 in approximately 300 adults with breast adenocarcinoma and 126 controls of Iranian women. In total, 426 Iranian sporadic breast cancer affected women compared to the control group were studied by PCR-RFLP for ERCC1 variant. RESULTS: The genotype ERCC1 TT has the highest frequency in both groups (36.6 in patients and 8.5 in controls). The genotype ERCC1 was the most important risk factor in our population [GG/AA odds ratio: 0.692, 95% confidence interval (CI): 0.4-1.199, p = 0.188; GG/AG odds ratio: 3.333, 95% CI: 1.917-5.795, p = 0.001; AA/AG odds ratio: 0.208, 95% CI: 0.124-0.348, p = 0.342]. CONCLUSIONS: Our patients was associated with breast cancer risk. |
format | Online Article Text |
id | pubmed-3460502 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-34605022012-10-09 ERCC1 intron 1 was associated with breast cancer risk Mojgan, Hosseini Massoud, Houshmand Ahmad, Ebrahimi Arch Med Sci Clinical Research INTRODUCTION: There are numerous studies addressing associations of polymorphisms in DNA repair genes and cancer risks because accurate and efficient DNA repair is crucial to genomic integrity and fidelity. ERCC1 is important in DNA nucleotide excision repair. MATERIAL AND METHODS: We genotyped constitutive variants of ERCC1 in approximately 300 adults with breast adenocarcinoma and 126 controls of Iranian women. In total, 426 Iranian sporadic breast cancer affected women compared to the control group were studied by PCR-RFLP for ERCC1 variant. RESULTS: The genotype ERCC1 TT has the highest frequency in both groups (36.6 in patients and 8.5 in controls). The genotype ERCC1 was the most important risk factor in our population [GG/AA odds ratio: 0.692, 95% confidence interval (CI): 0.4-1.199, p = 0.188; GG/AG odds ratio: 3.333, 95% CI: 1.917-5.795, p = 0.001; AA/AG odds ratio: 0.208, 95% CI: 0.124-0.348, p = 0.342]. CONCLUSIONS: Our patients was associated with breast cancer risk. Termedia Publishing House 2012-09-08 2012-09-08 /pmc/articles/PMC3460502/ /pubmed/23056077 http://dx.doi.org/10.5114/aoms.2012.30289 Text en Copyright © 2012 Termedia & Banach http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Research Mojgan, Hosseini Massoud, Houshmand Ahmad, Ebrahimi ERCC1 intron 1 was associated with breast cancer risk |
title | ERCC1 intron 1 was associated with breast cancer risk |
title_full | ERCC1 intron 1 was associated with breast cancer risk |
title_fullStr | ERCC1 intron 1 was associated with breast cancer risk |
title_full_unstemmed | ERCC1 intron 1 was associated with breast cancer risk |
title_short | ERCC1 intron 1 was associated with breast cancer risk |
title_sort | ercc1 intron 1 was associated with breast cancer risk |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460502/ https://www.ncbi.nlm.nih.gov/pubmed/23056077 http://dx.doi.org/10.5114/aoms.2012.30289 |
work_keys_str_mv | AT mojganhosseini ercc1intron1wasassociatedwithbreastcancerrisk AT massoudhoushmand ercc1intron1wasassociatedwithbreastcancerrisk AT ahmadebrahimi ercc1intron1wasassociatedwithbreastcancerrisk |